OM-85 Broncho-Vaxom<sup>®</sup>, a Bacterial Lysate, Reduces SARS-CoV-2 Binding Proteins on Human Bronchial Epithelial Cells
In clinical studies, OM-85 Broncho-Vaxom<sup>®</sup>, a bacterial lysate, reduced viral respiratory tract infection. Infection of epithelial cells by SARS-CoV-2 depends on the interaction of its spike-protein (S-protein) with host cell membrane proteins. In this study, we investigated th...
Main Authors: | Lei Fang, Liang Zhou, Michael Tamm, Michael Roth |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/9/11/1544 |
Similar Items
-
Effect of Broncho-Vaxom (OM-85) on the frequency of chronic obstructive pulmonary disease (COPD) exacerbations
by: Joon Young Choi, et al.
Published: (2023-10-01) -
The role of bacterial lysates in the treatment of respiratory diseases
by: N. P. Knyazheskaya
Published: (2013-12-01) -
Can bacterial lysates be useful in prevention of viral respiratory infections in childhood? The results of experimental OM-85 studies
by: Stefania Ballarini, et al.
Published: (2022-11-01) -
Microbiota profiles in pre-school children with respiratory infections: Modifications induced by the oral bacterial lysate OM-85
by: Susanna Esposito, et al.
Published: (2022-08-01) -
Airway Administration of Bacterial Lysate OM-85 Protects Mice Against Respiratory Syncytial Virus Infection
by: Krist Helen Antunes, et al.
Published: (2022-05-01)